reMYND NV
Latest round
- Series B
Last raised
- Aug 2020
Total raised
- $27M
Investors
- 6
About reMYND NV
Founded in 2002 in Leuven, Belgium, reMYND NV is dedicated to addressing age-related neurodegenerative diseases through innovative therapies. The company has undergone strategic pivots, including an emphasis on developing a contract research organization (CRO) division to collaborate with global pharmaceutical firms. The founder, Joris Winderickx, has a history in the biotech space, although further details about previous ventures are not specified.reMYND focuses on first-in-class oral treatments for neurodegenerative diseases, particularly Alzheimer’s and Huntington’s disease. Their innovative therapeutics aim to restore synaptic function and mitigate amyloid-beta and tau pathologies. The company also explores mitochondrial dysfunction related to Amyotrophic Lateral Sclerosis (ALS).10 for the year 2022. The company is also exploring strategic expansions into new geographical markets to bolster its research capabilities and strengthen partnerships with pharmaceutical entities.
Who invested in reMYND NV
6 investors across 2 rounds
See all investors in reMYND NV
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about reMYND NV
Who invested in reMYND NV?
reMYND NV has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has reMYND NV raised?
reMYND NV has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did reMYND NV last raise money?
reMYND NV's most recent round on record is a Series B, in Aug 2020.
What does reMYND NV do?
Founded in 2002 in Leuven, Belgium, reMYND NV is dedicated to addressing age-related neurodegenerative diseases through innovative therapies.
Where is reMYND NV headquartered?
reMYND NV is headquartered in Leuven, Belgium.
Which VCs invest in companies like reMYND NV?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back pharmaceuticals companies at reMYND NV's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like reMYND NV? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.